Early Career Network – Member Spotlight Interview Dr Zoé Colombet Early Career Network – Member Spotlight Interview Dr Zoé Colombet ECN Spotlight
COMs Webinar – MASLD & Obesity: Mechanisms & Management – Tuesday 28th October 2025 at 12:30-13:30 CET COMs Webinar – MASLD & Obesity: Mechanisms & Management – Tuesday 28th October 2025 at 12:30-13:30 CET COMs, Education, Upcoming Events, Webinar
Welcome to ECO 2024 – Watch EASO President Jason Halford discuss this years congress Welcome to ECO 2024 – Watch EASO President Jason Halford discuss this years congress May 10, 2024 EASO Secretariat ECO ECO2024 Pre-Congress Share with your network Share on Facebook Share on Twitter Share on Linkedin Share via Email
Early Career Network – Member Spotlight Interview Dr Zoé Colombet Early Career Network – Member Spotlight Interview Dr Zoé Colombet ECN Spotlight
COMs Webinar – MASLD & Obesity: Mechanisms & Management – Tuesday 28th October 2025 at 12:30-13:30 CET COMs Webinar – MASLD & Obesity: Mechanisms & Management – Tuesday 28th October 2025 at 12:30-13:30 CET COMs, Education, Upcoming Events, Webinar
Effect of sweeteners and sweetness enhancers on weight management and gut microbiota composition in individuals with overweight or obesity: the SWEET study Effect of sweeteners and sweetness enhancers on weight management and gut microbiota composition in individuals with overweight or obesity: the SWEET study EU Projects, Research
Understanding Obesity: More than Weight Understanding Obesity: More than Weight Education, Infographics, Research
BASORD is celebrating its 30th anniversary in 2025! BASORD is celebrating its 30th anniversary in 2025! Education, Member News
Pediatric Obesity Training Course: APTO Pediatric Obesity Training Course: APTO Childhood Obesity, Education
Italy Approves the First Law Recognizing Obesity as a Chronic Disease Italy Approves the First Law Recognizing Obesity as a Chronic Disease Member News, Policy
Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Research